Covid-19

Why did The Queen’s Pirbright Institute PATENT the “CORONAVIRUS” on Nov. 20, 2018? (AND why does the UK control the U.S. Patent Office?)

Posted on by 1 Comment

Patent No.: US 10m 130, 701 B2
Date of Patent: Nov. 20, 2018

ABSTRACT

The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in or more of non-structural proteins(s) (nsp)-10, nsp-15, or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.

Click to access 2018-11-20-US-Pat-No-10130701-CORONAVIRUS-Assignee-THE-PIRBRIGHT-INSTUTUTE-Woking-Great-Britain-funded-by-Wellcome-Trust-and-Gates-Foundation-USPTO-Nov-20-2018.pdf

One thought on “Why did The Queen’s Pirbright Institute PATENT the “CORONAVIRUS” on Nov. 20, 2018? (AND why does the UK control the U.S. Patent Office?)”

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s